Circulating tumor cells and response to chemotherapy in metastatic breast cancer: SWOG S0500 - Wikidata - wikimedia - TriplyDB

Circulating tumor cells and response to chemotherapy in metastatic breast cancer: SWOG S0500

Circulating tumor cells and response to chemotherapy in metastatic breast cancer: SWOG S0500

http://www.wikidata.org/entity/Q34402487

about

Minimal residual disease in breast cancer: an overview of circulating and disseminated tumour cells Molecular Imaging of Biomarkers in Breast Cancer Circulating tumor cells in breast cancer Characterization of DNA Methylation in Circulating Tumor Cells Circulating tumor cells isolation: the "post-EpCAM era"Circulating Tumor Cells: A Window Into Tumor Development and Therapeutic Effectiveness Dynamic changes in numbers and properties of circulating tumor cells and their potential applications The promise of circulating tumor cell analysis in cancer management Application of optically-induced-dielectrophoresis in microfluidic system for purification of circulating tumour cells for gene expression analysis- Cancer cell line model Circulating and disseminated tumor cells: diagnostic tools and therapeutic targets in motion Dissecting the Heterogeneity of Circulating Tumor Cells in Metastatic Breast Cancer: Going Far Beyond the Needle in the Haystack Pancreatic cancer: Are "liquid biopsies" ready for prime-time?Circulating Tumor Cells and Circulating Tumor DNA Provide New Insights into Pancreatic Cancer Response biomarkers: re-envisioning the approach to tailoring drug therapy for cancer Potential Role of Circulating Tumor Cell Detection and Monitoring in Breast Cancer: A Review of Current Evidence Using circulating tumor cells to inform on prostate cancer biology and clinical utility Detecting Blood-Based Biomarkers in Metastatic Breast Cancer: A Systematic Review of Their Current Status and Clinical Utility.Nanotechnology for enrichment and detection of circulating tumor cells.Sensitive detection of viable circulating tumor cells using a novel conditionally telomerase-selective replicating adenovirus in non-small cell lung cancer patients Single cell mutational analysis of PIK3CA in circulating tumor cells and metastases in breast cancer reveals heterogeneity, discordance, and mutation persistence in cultured disseminated tumor cells from bone marrow.Use of Biomarkers to Guide Decisions on Systemic Therapy for Women With Metastatic Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Development of circulating tumor cell-endocrine therapy index in patients with hormone receptor-positive breast cancer.Significance of Circulating Tumor Cells in Metastatic Triple-Negative Breast Cancer Patients within a Randomized, Phase II Trial: TBCRC 019 Molecular profiling of single circulating tumor cells with diagnostic intention.CTC enumeration and characterization: moving toward personalized medicine.Circulating tumor cells as early predictors of metastatic spread in breast cancer patients with limited metastatic dissemination.May CTC technologies promote better cancer management?Clinical implications of circulating tumor cells of breast cancer patients: role of epithelial-mesenchymal plasticity Prognostic Relevance of Circulating Tumor Cells in Molecular Subtypes of Breast Cancer.Do circulating tumor cells, exosomes, and circulating tumor nucleic acids have clinical utility? A report of the association for molecular pathology Development of a microfluidic-based optical sensing device for label-free detection of circulating tumor cells (CTCs) through their lactic acid metabolism.Analytical and Clinical Validation of a Digital Sequencing Panel for Quantitative, Highly Accurate Evaluation of Cell-Free Circulating Tumor DNA Cancer biomarker discovery and validation.Phase II Study of Lapatinib in Combination With Trastuzumab in Patients With Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer: Clinical Outcomes and Predictive Value of Early [18F]Fluorodeoxyglucose Positron Emission Tomogr In patients with metastatic breast cancer the identification of circulating tumor cells in epithelial-to-mesenchymal transition is associated with a poor prognosis.Clinical Significance of Circulating Tumor Cells in Peripheral Blood of Patients with Esophageal Squamous Cell Carcinoma.A novel approach for next-generation sequencing of circulating tumor cells Phase II studies of two different schedules of dasatinib in bone metastasis predominant metastatic breast cancer: SWOG S0622 Nanoroughened adhesion-based capture of circulating tumor cells with heterogeneous expression and metastatic characteristics Exploratory Analysis of TP53 Mutations in Circulating Tumour DNA as Biomarkers of Treatment Response for Patients with Relapsed High-Grade Serous Ovarian Carcinoma: A Retrospective Study

P2860

Q26748850-A9DAF07C-4582-4CCF-B8F1-A4DE04ADA5F7 Q26772870-6ECECC43-6B75-404C-8982-2FCE9B914F6A Q26774808-AFFFCD1A-0A7F-41D2-B5D7-0F9408A1D84D Q26778427-9D763E61-C051-440D-8A17-7B4BCE1B3C6A Q26778917-B70A1E3B-1C71-4B53-81CC-A29F6D52E58D Q26827815-1481C5CE-9155-4D3E-A513-6CA14EA38DB2 Q26853569-E28067D6-0F59-4859-A8D7-4EF1950D3C63 Q27022113-993FE2C5-5743-4AEF-BE21-510127A55F7A Q27349679-5E1A8564-0267-4ACC-B00A-B3EBC7D9A37F Q28066285-35B69DFB-3520-4B1C-AF24-D0D6D10E75E4 Q28067549-2D604309-B6AB-4ABB-AEC0-26A99523A77B Q28068665-0FB33149-92D0-4951-9843-87FD4B3BC784 Q28073765-21473FF4-CBF1-497F-96F9-73855E59B6AD Q28074295-B74A0613-CA2C-4482-A00E-AEAEFC6B4CB1 Q28075850-62B7E037-154C-47D2-A779-68E3695AD522 Q28083261-D6303B45-7D7C-4869-B7D1-7E70A5A6B738 Q30238465-88E58EA1-9468-472E-B7CB-27AD0E1250BF Q30382502-EC0E19CE-3962-4F06-96C2-206ABBD19E6F Q33798634-01B1C4F3-CDE2-4F63-9149-25D28A1A7754 Q33806957-275F1EE1-8E8F-442A-86AE-3129B4D1DDBC Q33817285-2657B4A2-4D9C-4596-B209-771A8F170D94 Q33917455-B8DC0203-7BEE-4255-BBE3-A4986A7B3323 Q33923080-2D64F7F1-4D0E-48FA-B173-B5F6EE3F5706 Q34542660-853AC6ED-1960-4E39-8340-2A872C037754 Q34577724-3CCBCF1D-46A0-455D-A9BD-145F76C93A46 Q35000278-42AA2651-6067-49A9-8458-E01FFFAE6421 Q35016353-BB11459A-2102-45E0-8080-3542BBF7D16A Q35124176-563B06F3-87A2-4136-ACE3-DA882F4D9122 Q35427994-C4A77910-AF6A-4B46-8E38-80EA9FE0B333 Q35543094-42707231-697F-4A71-9186-23CD87209636 Q35617933-AB2E32B2-4E1E-4BA2-9371-ABC41907CF6F Q35810461-CB381C87-1596-4EC5-99D7-94484C69F29A Q35879887-A91D1859-2F97-497D-8FD0-5AAE0F1F1BFC Q35947019-65195107-C2BA-4AFB-8A4F-B1AAA925E0F0 Q35951699-4E205956-FE78-44A9-996B-E86B3FB53476 Q36048588-7562AFC4-CCDA-42EB-8412-5E8C66D19838 Q36088952-D2192B5E-4580-4664-BA6F-FD7B1A7921B8 Q36090747-EB892EF1-CBEB-44F4-BF01-A92A8808F4C8 Q36097761-EADB8AB4-636F-4D6B-AA94-323314AFCB19 Q36229421-24DCF714-8819-4C9F-A637-03A152430341

P2860

Circulating tumor cells and response to chemotherapy in metastatic breast cancer: SWOG S0500

http://www.wikidata.org/entity/Q34402487

description

2014 nî lūn-bûn

@nan

2014 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Circulating tumor cells and re ...... atic breast cancer: SWOG S0500

@ast

Circulating tumor cells and re ...... atic breast cancer: SWOG S0500

@en

Circulating tumor cells and re ...... atic breast cancer: SWOG S0500

@nl

type

label

Circulating tumor cells and re ...... atic breast cancer: SWOG S0500

@ast

Circulating tumor cells and re ...... atic breast cancer: SWOG S0500

@en

Circulating tumor cells and re ...... atic breast cancer: SWOG S0500

@nl

prefLabel

Circulating tumor cells and re ...... atic breast cancer: SWOG S0500

@ast

Circulating tumor cells and re ...... atic breast cancer: SWOG S0500

@en

Circulating tumor cells and re ...... atic breast cancer: SWOG S0500

@nl

P1433

Q34402487-5EF69377-AA67-4CBF-B186-09915A58A4F4

P1476

Q34402487-2B531DC5-2401-485A-9F7E-4293998B1CB7

P2093

Q34402487-0431281A-6447-40DA-90C7-A7EDFCBFDCA1

Q34402487-19174D1B-6826-4FDC-BBAF-948842298704

Q34402487-1F063ED3-BBCD-4029-8E20-F456D532D80B

Q34402487-240FE0F8-BED0-4764-98C2-CAA69D5D5309

Q34402487-3F36AF99-0B5A-490C-9F5D-85A876234AB6

Q34402487-5E70B456-DDBC-42AE-8582-677A844C8B14

Q34402487-9926F45C-4DCA-46DC-AE5A-A33B6AE11BCC

Q34402487-9B8172F9-893D-46AE-92E4-82953474F0D2

Q34402487-B0EF2C0F-8F2B-48A4-901C-DC07E398B6EA

Q34402487-C7921363-BADB-4118-9D95-39A5A819535D

P2860

Q34402487-0CE9F530-7A3A-4FCC-9A89-965AA9B35C2F

Q34402487-18A75CB3-7294-428B-AC5C-7DB6B4AE17A8

Q34402487-2A1FD23A-EE44-4171-B126-1C693EFE4932

Q34402487-3D7E5FEF-B03F-4D45-B8E7-421CAD222316

Q34402487-4D1DC47C-0B75-4221-BADE-D0E734AB589E

Q34402487-6C067F19-2554-4D64-9DF5-78131D0878DE

Q34402487-733F46B7-2F1C-4A1E-B953-64C0ECFDCC29

Q34402487-80BCC379-759B-4603-8D10-661327D0AC4F

Q34402487-9B9C4D57-91DE-4A1C-8F21-D76B76640E53

Q34402487-D0A75172-0267-471D-8A86-E2F78553B456

P304

Q34402487-7634BE0A-04F1-425A-9206-50C4B999C06F

P31

Q34402487-F58E4497-9557-4D59-B2A1-CCA3FDC42158

P356

Q34402487-24E1F482-12ED-463C-8CA1-699A7D095D83

P407

Q34402487-9AC4F26E-8740-400D-BEC8-026ED28D6B32

P433

Q34402487-8510BB87-CAF9-413C-88D3-4D30138C9655

P478

Q34402487-FC605E09-D3B3-4BD4-90C2-A224B01043D4

P577

Q34402487-9944EA8B-0EE3-48E4-B224-559112AB9F02

P698

Q34402487-0B27274C-735C-45B0-98CF-06798C97F021

P921

Q34402487-5C839191-67A5-48CF-9267-F5DB3199D51F

P932

Q34402487-752826A2-1C97-416D-875D-A3F74BE139E3

P356

JCO.2014.56.2561

P1433

Journal of Clinical Oncology

P1476

Circulating tumor cells and re ...... atic breast cancer: SWOG S0500

@en

P2093

Anne F Schott

http://www.w3.org/2001/XMLSchema#string

Brian Leyland-Jones

http://www.w3.org/2001/XMLSchema#string

Daniel F Hayes

http://www.w3.org/2001/XMLSchema#string

Danika L Lew

http://www.w3.org/2001/XMLSchema#string

Eric P Winer

http://www.w3.org/2001/XMLSchema#string

Gabriel N Hortobagyi

http://www.w3.org/2001/XMLSchema#string

Gerald V Doyle

http://www.w3.org/2001/XMLSchema#string

Gordan Srkalovic

http://www.w3.org/2001/XMLSchema#string

Jeffrey B Smerage

http://www.w3.org/2001/XMLSchema#string

Julie R Gralow

http://www.w3.org/2001/XMLSchema#string

P2860

Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases

Analysis of circulating tumor DNA to monitor metastatic breast cancer

Circulating tumor cells, disease progression, and survival in metastatic breast cancer

Personalized oncology through integrative high-throughput sequencing: a pilot study.

The impact of new chemotherapeutic and hormone agents on survival in a population-based cohort of women with metastatic breast cancer.

Combination versus sequential single-agent therapy in metastatic breast cancer.

Semiautomated isolation and molecular characterisation of single or highly purified tumour cells from CellSearch enriched blood samples using dielectrophoretic cell sorting.

Circulating tumor cells: a useful predictor of treatment efficacy in metastatic breast cancer.

Tumor metastasis: moving new biological insights into the clinic.

International guidelines for management of metastatic breast cancer (MBC) from the European School of Oncology (ESO)-MBC Task Force: Surveillance, staging, and evaluation of patients with early-stage and metastatic breast cancer.

P304

3483-3489

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1200/JCO.2014.56.2561

http://www.w3.org/2001/XMLSchema#string

P407

P433

31

http://www.w3.org/2001/XMLSchema#string

P478

32

http://www.w3.org/2001/XMLSchema#string

P577

2014-06-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24888818

http://www.w3.org/2001/XMLSchema#string

P921

P932

4209100

http://www.w3.org/2001/XMLSchema#string